Search

Displaying results 8421 - 8430 of 10000 in total
  1. Drug

    Lamifiban

    go.drugbank.com/drugs/DB20451
    Experimental

    Lamifiban has a monoisotopic molecular weight of 468.2 Da. … The usage of the INN stem '-fiban' in the name indicates that Lamifiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).

  2. Drug

    Lotrafiban

    go.drugbank.com/drugs/DB20872
    Experimental

    Lotrafiban has a monoisotopic molecular weight of 428.24 Da. … The usage of the INN stem '-fiban' in the name indicates that Lotrafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).

  3. Drug

    Tanogitran

    go.drugbank.com/drugs/DB21367
    Investigational

    Tanogitran has a monoisotopic molecular weight of 477.25 Da. … Tanogitran is under investigation in clinical trial NCT02254057 (Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects).

  4. Drug

    Pixavir marboxil

    go.drugbank.com/drugs/DB21589
    Experimental

    The usage of the INN stem '-xavir' in the name indicates that Pixavir marboxil is a influenza CAP-dependent endonuclease inhibitor. Pixavir marboxil has a monoisotopic molecular weight of 540.12 Da.

  5. Drug

    VPM1002

    go.drugbank.com/drugs/DB15801
    Investigational

    into the cytosol of the host cell due to Listeriolysin O expression in this vaccine. … BCG versions due to the lack of the RD2 genome segment.

  6. Drug

    Adakitug

    go.drugbank.com/drugs/DB05484
    Investigational

    Trials will initially focus on studies to treat glioblastoma, a cancer of the central nervous system.

  7. Drug

    Molybdenum

    go.drugbank.com/drugs/DB11137
    ApprovedInvestigational

    As it is not a naturally occuring free metal on Earth, molybdenum is found only in various oxidation states in minerals.

  8. Drug

    Garenoxacin

    go.drugbank.com/drugs/DB06160
    Experimental

    Garenoxacin, a quinolone antibiotic, is being investigated for the treatment of gram-positive and gram-negative bacterial infections.

  9. Drug

    VTP-194204

    go.drugbank.com/drugs/DB11806
    Investigational

    Nrx194204 has been used in trials studying the treatment of Parkinson's Disease and Non-small Cell Lung Cancer.

  10. Drug

    Murepavadin

    go.drugbank.com/drugs/DB14777
    Investigational

    Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).